Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Figure 3

The relative expression level of nine prognostic genes (ERBB2, GLOD5, KCNK6, MAL, MUCL1, OR2W3, RBP2, STAC, and ZNF829) between patients with TP53 mutation or not: (a) ERBB2; (b) GLOD5; (c) KCNK6; (d) MAL; (e) MUCL1; (f) OR2W3; (g) RBP2; (h) STAC; (i) ZNF829.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)